Ross is a strategy insights and planning manager in ZS’s New York office and a leader in the pipeline and launch strategy practice area, where he focuses primarily on commercialization and launch for biopharma clients.
Ross has nine years of life sciences consulting experience across a range of business issues, including portfolio strategy and optimization, business development evaluation, go-to-market strategy, opportunity assessments and forecasting, commercial organizational design, launch readiness and commercial excellence. Ross has consulted for 20-plus organizations ranging from VC-backed emerging biotech companies to Fortune 500 pharmaceutical companies. Ross’s experience spans a wide array of therapeutic areas, with significant focus in immunology, oncology and rare disease. Across these engagements, Ross has played a key role in client and project management, research development and project execution.
Ross joined ZS in 2011 as an associate. He has held numerous positions at the firm.
Ross holds a bachelor’s of engineering with honors from Vanderbilt University.